Cell surface biotinylation to identify the receptors involved in nanoparticle uptake into endothelial cells
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Vitronectin, a plasma glycoprotein that bridges integrin receptors expressed at the neurovascular interface, may further stabilize nanoparticle docking at the luminal endothelial surface through integrin αvβ3/αvβ5 engagement 40 .”
From High-density Lipoprotein Inspired Lipid Nanoparticles for Systemic RNA delivery to the Brain (2026) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schöttler, S., Becker, G., Winzen, S., Steinbach, T., Mohr, K., Landfester, K., Mailänder, V., & Wurm, F. R. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2015.330 · Cited by 1,272
A holistic approach to targeting disease with polymeric nanoparticles
Cheng, C. J., Tietjen, G. T., Saucier-Sawyer, J. K., & Saltzman, W. M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4503 · Cited by 480
Mapping protein binding sites on the biomolecular corona of nanoparticles
Kelly, P. M., Åberg, C., Polo, E., O'Connell, A., Cookman, J., Fallon, J., Krpetić, Ž., & Dawson, K. A. (2015) · Nature Nanotechnology · doi:10.1038/nnano.2015.47 · Cited by 360
Clathrin-independent pathways do not contribute significantly to endocytic flux
Bitsikas, V., Corrêa, I. R., & Nichols, B. J. (2014) · eLife · doi:10.7554/elife.03970 · Cited by 199
Research works printed but not linked: 53
- Wolfram, 2019, Clinical cancer nanomedicine, Nano Today, 25, 85, 10.1016/j.nantod.2019.02.005 · DOI · Paper page
- Shi, 2017, Cancer nanomedicine: progress, challenges and opportunities, Nat. Rev. Cancer., 17, 20, 10.1038/nrc.2016.108 · DOI · Paper page
- D'Mello, 2017, The evolving landscape of drug products containing nanomaterials in the United States, Nat. Nanotechnol., 12, 523, 10.1038/nnano.2017.67 · DOI · Paper page
- Degors, 2019, Carriers break barriers in drug delivery: endocytosis and endosomal escape of gene delivery vectors, Acc. Chem. Res., 52, 1750, 10.1021/acs.accounts.9b00177 · DOI · Paper page
- Wilhelm, 2016, Analysis of nanoparticle delivery to tumours, Nat. Rev. Mater., 1, 1, 10.1038/natrevmats.2016.14 · DOI · Paper page
- Salvati, 2013, Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface, Nat. Nanotechnol., 8, 137, 10.1038/nnano.2012.237 · DOI · Paper page
- Monopoli, 2012, Biomolecular coronas provide the biological identity of nanosized materials, Nat. Nanotechnol., 7, 779, 10.1038/nnano.2012.207 · DOI · Paper page
- Cedervall, 2007, Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles, Proc. Natl. Acad. Sci. U. S. A., 104, 2050, 10.1073/pnas.0608582104 · DOI · Paper page
- Monopoli, 2011, Physical−Chemical Aspects of Protein Corona: relevance to in Vitro and in Vivo Biological Impacts of Nanoparticles, J. Am. Chem. Soc., 133, 2525, 10.1021/ja107583h · DOI · Paper page
- Cox, 2018, Evolution of Nanoparticle Protein Corona across the Blood–Brain Barrier, ACS Nano, 12, 7292, 10.1021/acsnano.8b03500 · DOI · Paper page
- Barrán-Berdón, 2013, Time Evolution of Nanoparticle–Protein Corona in Human Plasma: relevance for Targeted Drug Delivery, Langmuir, 29, 6485, 10.1021/la401192x · DOI · Paper page
- Frost, 2017, Real-time in situ analysis of biocorona formation and evolution on silica nanoparticles in defined and complex biological environments, Nanoscale, 9, 3620, 10.1039/C6NR06399C · DOI
- Hadjidemetriou, 2016, Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles, Nanoscale, 8, 6948, 10.1039/C5NR09158F · DOI · Paper page
- Cheon, 2019, The Future of Nanotechnology: cross-disciplined Progress to Improve Health and Medicine, Acc. Chem. Res., 52, 2405, 10.1021/acs.accounts.9b00423 · doi:10.1021/acs.accounts.9b00423
- Tenzer, 2013, Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology, Nat. Nanotechnol., 8, 772, 10.1038/nnano.2013.181 · DOI · Paper page
- Deng, 2011, Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation, Nat. Nanotechnol., 6, 39, 10.1038/nnano.2010.250 · DOI · Paper page
- Pelaz, 2015, Surface Functionalization of Nanoparticles with Polyethylene Glycol: effects on Protein Adsorption and Cellular Uptake, ACS Nano, 9, 6996, 10.1021/acsnano.5b01326 · DOI · Paper page
- Francia, 2019, Corona Composition Can Affect the Mechanisms Cells Use to Internalize Nanoparticles, ACS Nano, 13, 11107, 10.1021/acsnano.9b03824 · DOI · Paper page
- Kim, 2014, Suppression of nanoparticle cytotoxicity approaching in vivo serum concentrations: limitations of in vitro testing for nanosafety, Nanoscale, 6, 14180, 10.1039/C4NR04970E · DOI
- Dobrovolskaia, 2016, Current understanding of interactions between nanoparticles and the immune system, Toxicol. Appl. Pharmacol., 299, 78, 10.1016/j.taap.2015.12.022 · DOI · Paper page
- Ritz, 2015, Protein Corona of Nanoparticles: distinct Proteins Regulate the Cellular Uptake, Biomacromolecules, 16, 1311, 10.1021/acs.biomac.5b00108 · DOI · Paper page
- Walkey, 2014, Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles, ACS Nano, 8, 2439, 10.1021/nn406018q · DOI · Paper page
- Yin, 2019, Intrapulmonary Cellular-Level Distribution of Inhaled Nanoparticles with Defined Functional Groups and Its Correlations with Protein Corona and Inflammatory Response, ACS Nano, 13, 14048, 10.1021/acsnano.9b06424 · DOI
- Lara, 2017, Identification of Receptor Binding to the Biomolecular Corona of Nanoparticles, ACS Nano, 11, 1884, 10.1021/acsnano.6b07933 · DOI · Paper page
- Lo Giudice, 2016, situ characterization of nanoparticle biomolecular interactions in complex biological media by flow cytometry, Nat. Commun., 7, 13475, 10.1038/ncomms13475 · DOI · Paper page
- Lara, 2018, Differential Recognition of Nanoparticle Protein Corona and Modified Low-Density Lipoprotein by Macrophage Receptor with Collagenous Structure, ACS Nano, 12, 4930, 10.1021/acsnano.8b02014 · DOI
- Leser, 1996, The paramyxovirus simian virus 5 hemagglutinin-neuraminidase glycoprotein, but not the fusion glycoprotein, is internalized via coated pits and enters the endocytic pathway, Mol. Biol. Cell., 7, 155, 10.1091/mbc.7.1.155 · DOI
- Meulendyke, 2005, Endocytosis Plays a Critical Role in Proteolytic Processing of the Hendra Virus Fusion Protein, J. Virol., 79, 12643, 10.1128/JVI.79.20.12643-12649.2005 · DOI
- Ito, 2014, Involvement of insulin-degrading enzyme in insulin-and atrial natriuretic peptide-sensitive internalization of amyloid-β peptide in mouse brain capillary endothelial cells, J. Alzheimer's Dis., 38, 185, 10.3233/JAD-122077 · DOI · Paper page
- Cihil, 2013, The Cell-based l-Glutathione Protection Assays to Study Endocytosis and Recycling of Plasma Membrane Proteins, J. Vis. Exp., 82, 50867
- Tham, 2017, Determining cell-surface expression and endocytic rate of proteins in primary astrocyte cultures using biotinylation, J. Vis. Exp., 2017, e55974
- Ito, 2020, Identification of cell-surface proteins endocytosed by human brain microvascular endothelial cells in vitro, Pharmaceutics, 12, 579, 10.3390/pharmaceutics12060579 · DOI
- Aliyandi, 2020, Effect of endothelial cell heterogeneity on nanoparticle uptake, Int. J. Pharm., 587, 10.1016/j.ijpharm.2020.119699 · DOI
- Gromnicova, 2016, Transport of Gold Nanoparticles by Vascular Endothelium from Different Human Tissues, PLoS ONE, 11, 10.1371/journal.pone.0161610 · DOI
- Aliyandi, 2021, Correlating Corona Composition and Cell Uptake to Identify Proteins Affecting Nanoparticle Entry into Endothelial Cells, ACS Biomater. Sci. Eng., 7, 5573, 10.1021/acsbiomaterials.1c00804 · DOI
- Bewersdorff, 2017, The influence of surface charge on serum protein interaction and cellular uptake: studies with dendritic polyglycerols and dendritic polyglycerol-coated gold nanoparticles, Int. J. Nanomed., 12, 2001, 10.2147/IJN.S124295 · DOI
- Weksler, 2005, Blood-brain barrier-specific properties of a human adult brain endothelial cell line, FASEB J., 19, 1872, 10.1096/fj.04-3458fje · DOI · Paper page
- Parent, 2014, An immortalized human liver endothelial sinusoidal cell line for the study of the pathobiology of the liver endothelium, Biochem. Biophys. Res. Commun., 450, 7, 10.1016/j.bbrc.2014.05.038 · DOI
- Lesniak, 2012, Effects of the Presence or Absence of a Protein Corona on Silica Nanoparticle Uptake and Impact on Cells, ACS Nano, 6, 5845, 10.1021/nn300223w · DOI · Paper page
- Kim, 2015, Toxicity of silica nanoparticles depends on size, dose, and cell type, Nanomed. Nanotechnol. Biol. Med., 11, 1407, 10.1016/j.nano.2015.03.004 · DOI · Paper page
- Hühn, 2013, Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge, ACS Nano, 7, 3253, 10.1021/nn3059295 · DOI · Paper page
- Marano, 2011, Nanoparticles: molecular targets and cell signalling, Arch. Toxicol., 85, 733, 10.1007/s00204-010-0546-4 · DOI · Paper page
- Aliyandi, 2020, Disentangling Biomolecular Corona Interactions With Cell Receptors and Implications for Targeting of Nanomedicines, Front. Bioeng. Biotechnol., 8, 10.3389/fbioe.2020.599454 · DOI
- Elschenbroich, 2010, Isolation of cell surface proteins for mass spectrometry-based proteomics, Expert Rev. Proteomics., 7, 141, 10.1586/epr.09.97 · DOI
- Plow, 1991, Role of Cell-Surface Lysines in Plasminogen Binding to Cells: identification of α-Enolase as a Candidate Plasminogen Receptor, Biochemistry, 30, 1682, 10.1021/bi00220a034 · DOI · Paper page
- Tonigold, 2018, Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona, Nat. Nanotechnol., 13, 862, 10.1038/s41565-018-0171-6 · DOI · Paper page
- Francia, 2020, Interactions at the cell membrane and pathways of internalization of nano-sized materials for nanomedicine, Beilstein J. Nanotechnol., 11, 338, 10.3762/bjnano.11.25 · DOI
- Caracciolo, 2013, Selective Targeting Capability Acquired with a Protein Corona Adsorbed on the Surface of 1,2-Dioleoyl-3-trimethylammonium Propane/DNA Nanoparticles, ACS Appl. Mater. Interfaces., 5, 13171, 10.1021/am404171h · DOI · Paper page
- Arosio, 2012, Integrin-Mediated Drug Delivery in Cancer and Cardiovascular Diseases with Peptide-Functionalized Nanoparticles, Curr. Med. Chem., 19, 3128, 10.2174/092986712800784748 · doi:10.2174/092986712800784748
- Wang, 2010, Integrin targeted drug and gene delivery, Expert Opin. Drug Deliv., 7, 159, 10.1517/17425240903468696 · DOI
- Zuhorn, 2007, Adhesion receptors mediate efficient non-viral gene delivery, Mol. Ther., 15, 946, 10.1038/mt.sj.6300139 · DOI
- Kim, 2021, Cholesterol-Mediated Seeding of Protein Corona on DNA Nanostructures for Targeted Delivery of Oligonucleotide Therapeutics to Treat Liver Fibrosis, ACS Nano
- Bauer, 2020, Cell-type-specific differences in KDEL receptor clustering in mammalian cells, PLoS ONE, 15, 10.1371/journal.pone.0235864 · DOI
Cited by
High-density Lipoprotein Inspired Lipid Nanoparticles for Systemic RNA delivery to the Brain
Xu, Z., Shalin, K., Do, V., Yan, A., & Gao, J. (2026) · doi:10.64898/2026.05.29.728695 · Cited by 1
Metadata
- Authors
- Aliyandi, A., Reker-Smit, C., Zuhorn, I. S., & Salvati, A.
- Venue
- Acta Biomaterialia
- Publisher
- Elsevier BV
- Published
- 2023-01
- Volume
- 155
- Pages
- 507-520
- ISSN
- 1742-7061
- Cited by
- 18
- References
- 4
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- Universitair Medisch Centrum Groningen
- European Research Council (637614)
- Institut National de la Santé et de la Recherche Médicale
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.